Navigation Links
New Treatment For Tendonitis

Tendonitis occurs when a tendon near a joint becomes inflamed. Treatment is often difficult and recovery can be long. // Now, a new approach relieves the pain of this common condition.

Now, an increasing number of patients with tendonitis are finding relief with extracorporeal shock wave therapy. During the therapy, ultrasound energy targets the affected area. Doctors say it usually takes two to three 20-minute shock wave treatments to relieve the pain of chronic tendonitis.Numerous clinical studies have shown it to be effective in managing a wide variety of tendonopathy and chronic tendonitis syndromes.

Specialists say the shock waves inhibit pain in the nerve endings and increase blood flow, promoting healing. Specialists also say It's a safe non-invasive procedure and is comfortable for the patient, and is also well-tolerated.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment For Tendonitis

(Date:10/11/2008)... Barnett International, a division of ...d the release of The Form FDA 1572: A Reference Gu...rs. Designed for clinical investigators, clinical ...fessionals, and others involved in the clinical re...ide to address the Form FDA 1572-Statement of Inve...
(Date:10/10/2008)... to develop some form of disease by 20 years after...10 (HealthDay News) -- Liver transplant patients h...population, say researchers in Finland. , In a...r Transplantation , researchers investigated the c... recipients from Helsinki University Central Hospi...
(Date:10/10/2008)..., Wis., Oct. 10 /PRNewswire/ -- More than 600 new ...residential election. This is the,result of Aurora...hursday,Oct. 9, at all of the health care system,...f 658 people signed up to vote at the drives., Au... the Wisconsin,Government Accountability Board to ...
(Date:10/10/2008)... Upon the completion of a highly succe... CDM Media proudly announces their next business t...mation technology executives in healthcare. CDM Me...aunch May 10-12, 2009 at the Four Seasons Resort i...ulu, HI (PRWEB) October 11, 2008 -- Upon the compl...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2
... of trauma care are very few compared to other med...re would help in improving emergency treatments an... deaths caused by accidents//. More than 10,000 ...00,000 people are severely injured daily – mostly ...
...logy and Aging had found that less volume of white...ld age people is the cause of decline in brain act...ne in brain activity in the old people is not age ...e matter (frontal lobe) of the brain. Study found ...
...aunting India over the past decade. The problem is...as many as 459 AIDS related deaths over the past t...uring the period between January//, 2002 and Septe...d in the state. Furthermore, 641 persons were foun...
...he low life expectancy of Scottish people who have...west in United Kingdom where the countries average... years for women//. The low life expectancy of the...aid to be due to increased smoking and lack of exe...
Other Medicine News:Health News:Orissa found to be worst affected by the killer disease, AIDS 2
(Date:10/8/2008)... /PRNewswire-USNewswire/ -- The facts are,overwhel...AIDS in,sub-Saharan Africa. More than 35,000,000 w... already died of AIDS. The Foundation for Hospices...ing and their families,find compassion and relief ...ive partnering initiative links African hospices a...
(Date:10/8/2008)... to be Discontinued and Headcount to be Reduced, S...lio Review; Zanolimumab Program to be Discontinue... Employees, COPENHAGEN, Oc... GEN),announced today that it is discontinuing dev...n, as a result of a portfolio review and,assessmen...
(Date:10/8/2008)...RNewswire/ -- Vical Incorporated (Nasdaq: VICL ),... nonclinical data,demonstrating that the company,s...n DNA- and protein-based infectious disease vaccin...land, Pharm.D., Ph.D., Vical,s,Senior Vice Preside...oday,Wednesday, October 8, at the World Vaccine C...
(Date:10/7/2008)...y of new device for detecting polyps that can be ...RLANDO, Fla., Oct. 7 /- At the Americ...eeting in Orlando (ACG 2008), renowned,gastroenter...a,multi-institutional clinical study that evaluate...a new device that is designed to improve the abili...
Breaking Medicine Technology:In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Achieving CVIS Goals Webinar 13451 1Achieving CVIS Goals Webinar 13451 2Dana Foundation releases arts and cognition research 13448 1Dana Foundation releases arts and cognition research 13448 2Rare Gene Mutation Plays Role in Longevity 13445 1Rare Gene Mutation Plays Role in Longevity 13445 2Rare Gene Mutation Plays Role in Longevity 13445 3Argosy publishing launches The Visible Body 13442 1Argosy publishing launches The Visible Body 13442 2Argosy publishing launches The Visible Body 13442 3
...THERSBURG, Md., May 24, 2007 /PRNewswire-FirstCall...l announce results from the,Phase 1 trial of its p...e markets open tomorrow. A conference call and liv...omorrow to discuss,the results. , Conference Call ...y, May 25, 2007 at 8:30,a.m. Eastern Time via phon...
...IN, Texas--(BUSINESS WIRE)--May 29, 2007 - Introge...,s clinical,collaborators will report updated Phas...rapy product candidates at the upcoming,annual mee... (ASCO),in Chicago and the American Society of Gen...than ever, advancing pipeline of,first-in-class ca...
Other Medicine Technology:Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 3
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: